AG
REGN icon

Algert Global’s Regeneron Pharmaceuticals REGN Stock Holding History

Algert Global’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-636
Closed -$491K – 1304
2025
Q4 		$491K Buy
636
+100
+19% +$67.9K 0.01% 948
2025
Q3 		$301K Buy
536
+80
+18% +$45.2K 0.01% 994
2025
Q2 		$239K Buy
456
+2
+0.4% +$1.12K 0.01% 1077
2025
Q1 		$288K Buy
+454
New +$312K 0.01% 1022
2016
Q1 		– Sell
-1,700
Closed -$923K – 387
2015
Q4 		$923K Buy
+1,700
New +$921K 0.43% 82

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Algert Global's REGN Position: Q1 2026 in Review

Algert Global sold out of Regeneron Pharmaceuticals (REGN) in Q1 2026, closing a stake of 636 shares — an estimated $491K sold.

Algert Global first reported a position in REGN in Q4 2015 and held it in 5 quarters. The position peaked at $923K in Q4 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Algert Global reported no remaining Regeneron Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 636 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $491K.
  • Algert Global first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 5 quarters.
  • Algert Global's Regeneron Pharmaceuticals position peaked at $923K in Q4 2015.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.